Get started
HIMS & HERS HEALTH INCHIMS & HERS HEALTH INCHIMS & HERS HEALTH INC

HIMS & HERS HEALTH INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

HIMS trade ideas

$HIMS setting up for its next big move—here’s what I’m watching!🔥 NYSE:HIMS setting up for its next big move—here’s what I’m watching! 🔥 📉 Eyeing momentum down to $44-$48, and I’m not mad about it! 🔄 That flip from resistance to support is key for long-term price growth. 🚀 Bull flag breakout could come sooner—stay locked in! Keeping an eye on it all for the next trade entry on this beast! 💬 What’s your take? Are we bouncing or breaking out? Drop your thoughts below! ⬇️
NYSE:HIMSLong
by RonnieV29
2
HIMS – Technically and Fundamentally Strong for Mid-to-Long TermTechnical Analysis HIMS is trading in a clear ascending channel since 2023. On the daily chart, a “cup and handle” formation has completed, with a confirmed breakout above the neckline ($55–$57 area). The price is consolidating near the breakout point – classic behavior before a continuation move. Target projection from the cup pattern is $170+, implying a 200%+ upside potential. The stock also respects the upper trendline of the long-term channel, reinforcing bullish structure. Fundamental Strength: Telemedicine megatrend: Digital health is booming. HIMS is one of the few well-established D2C players in the U.S. market. Revenue growth: Annual revenue growth exceeds 40% YoY, a sign of operational efficiency and demand. Sticky subscription model: Over 1.5 million active subscribers — solid base for recurring revenue and LTV. Valuation upside: Still undervalued relative to sector peers despite recent rally. Scalable tech stack: Strong backend, customer acquisition systems, and vertically integrated infrastructure support further expansion. Conclusion: HIMS offers an attractive risk–reward setup for swing traders and long-term investors alike
NYSE:HIMSLong
by InvestWorld_777
Where is HIMS set to go next?Overview of Hims & Hers Health (NYSE: HIMS): Pros Expanding into weight-loss treatments -Hims successfully entered the high-demand GLP‑1 weight-loss space by selling compounded semaglutide during shortages. With branded Wegovy now available on their platform in partnership with Novo Nordisk, they’ve broadened their offering. Solid growth & rising profitability -Revenue surged ~18% in 2024 to $1.78 b ttm, with annual net income of $164 m. -Q1 2025 reported >100% YoY revenue growth ($586 m) with expected profit of 20¢/share. Strong gross margins -At around 80–88%, comparable to peer telehealth platforms. Diverse healthcare offerings -Beyond weight loss: sexual health, skincare, hair loss, mental health via DTC model. Expanded further via European acquisition of ZAVA (~1.3 m subscribers). Undervalued relative to future earnings -Analysts project 2030 revenues of $6.5 b—implying mid‑20s% CAGR. With projected EPS ~$1.5 b, current multiples (P/E ~40x) might look reasonable long term. Cons GLP‑1 strategy under pressure -The end of compounding allowances by FDA reduced their low-cost advantage. -Dependence on cash-pay vs. insurer coverage may limit growth if insurers cap co-pays. High valuation with risk -Trading at ~84x trailing EPS and ~70x forward EPS—wide margin for missteps. -Analysts average target at $38 (≈ 33% downside), 12 rate it a 'Hold'. Competitive & regulatory headwinds -Market crowded with telehealth players like Ro, Noom, CVS, and insurers which may undercut cash-pay model. -Legal scrutiny over “personalized” compounded products persists; Novo lawsuits underway. Reputation & controversy -CEO’s political donation stirred backlash; regulatory scrutiny around ads and compounding practices. -Platform has faced occasional service and customer trust issues. -Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial advice, investment recommendation, or an offer to buy or sell any securities. Stock prices, valuations, and performance metrics are subject to change and may be outdated. Always conduct your own due diligence and consult with a licensed financial advisor before making investment decisions. The information presented may contain inaccuracies and should not be solely relied upon for financial decisions. I am not personally liable for your own losses, this is not financial advise.
NYSE:HIMS
by bossout10
1
HIMS – Long Setup | Potential 60% MoveHims & Hers (HIMS) just gave us a textbook Ichimoku breakout and is holding strong above the cloud after a healthy pullback. Technical Breakdown: Price above Kumo Cloud: Bullish structure intact. Support held at $54.62 – key base above cloud and Tenkan-sen. MACD is curling back after a corrective wave, showing early signs of momentum returning. Risk/Reward: 8.59 – Extremely favorable. Target: $93.58 (60.22% upside) Stop: $51.78 (7.01% downside) Rationale: HIMS continues to ride bullish sentiment in the healthcare and telemedicine sectors. This chart has a clean continuation setup with institutional buy zones likely around $54-$55. Risk is tightly controlled, and upside potential is significant.
NYSE:HIMSLong
by aaronkaltman
1
HIMS Weekly Options Outlook — June 3, 2025📉 HIMS Weekly Options Outlook — June 3, 2025 🚨 AI Model Consensus: Moderately Bearish into June 6 Expiry 🧠 Model Overview 🔹 Grok (xAI) Bias: Neutral Setup: Bearish short-term, bullish long-term; mixed outlook Trade: No action — lacks edge Confidence: 35% 🔹 Claude (Anthropic) Bias: Moderately Bearish Setup: Below EMAs, bearish MACD; cautious sentiment Trade: Buy $52P @ $0.94 → PT $1.88+, SL $0.56 Confidence: 72% 🔹 Llama (Meta) Bias: Moderately Bearish Setup: Post-run fractal pullback, mixed but leaning down Trade: Buy $52P → PT +20%, SL −50% Confidence: 70% 🔹 Gemini (Google) Bias: Moderately Bearish Setup: Clean break under EMAs, MACD/RSI confirm weakness Trade: Buy $50P @ ~$0.47 → PT 100%, SL 50% Confidence: 65% 🔹 DeepSeek Bias: Moderately Bearish Setup: Breakdown across timeframes; skewed put flow Trade: Buy $50P @ $0.45 → PT $0.70, SL $0.32 Confidence: 65% ✅ Consensus Summary 📉 4 of 5 models recommend bearish weekly puts 🔻 Clear breakdown under EMAs with supportive MACD/RSI signals 🧲 Max Pain at $55 could cause late-week pullback or stall 🎯 Preferred strategy: OTM naked puts with high ROI potential 🎯 Recommended Trade Setup 💡 Strategy: Weekly Bearish Put Play 🔘 Ticker: HIMS 📉 Direction: PUT 🎯 Strike: $52 💵 Entry: $0.94 (ask) 🎯 Profit Target: $1.70 (+80%) 🛑 Stop Loss: $0.56 (−40%) 📏 Size: 1 contract 📅 Expiry: 2025-06-06 ⏰ Entry Timing: Market Open 📈 Confidence: 70% ⚠️ Risk Factors to Watch 🧲 Max pain at $55 could slow breakdown or cause snapback 🔻 $52 support zone may cause consolidation or chop 📉 Falling VIX = compressed premiums, slower option movement ⌛ Theta accelerates into Thursday/Friday — exit early if flat
NYSE:HIMSShort
by quantsignals
HIMS 1D — This pattern didn’t cook for nothingOn the daily chart of Hims & Hers Health, we’re looking at a textbook cup with handle formation — not just a pattern, but a structure backed by time, volume, and classic price behavior. The base of the cup formed steadily from February to May 2025, and as soon as the curve was complete, price transitioned into a tight consolidation — the "handle" that often masks real accumulation. Right now, price is testing the resistance area. And it’s not just floating up there — it’s coming in hot: price has already broken through EMA 20/50/100/200 and SMA 50/200. That’s a full stack flip. This isn’t sideways noise — it’s a structural shift in control. Volume is starting to build as price rises, confirming that demand is real and institutional positioning likely active. We’re watching a breakout zone above the handle — and when that breaks, the structure unlocks with a clear target: $107.25, roughly a 2x move from current levels. This setup isn’t noise. It’s a long-cooked formation that’s now about to boil over. If the handle holds and price breaks through — the rest is just follow-through.
NYSE:HIMSLong
by TotoshkaTrades
11
Safe Entry Zone HIMSAfter reaching the Target with 150% profit. Now the Blue Zone IC Zone(Interesting Zone or Institutional Candles Zone) is most appealing support level where we wait for Potentional of Strong Buyers to Step In. Note: Potentional of Strong Buying Zone: We have two scenarios must happen at The Mentioned Zone: Scenarios One: strong buying volume with reversal Candle. Scenarios Two: Fake Break-Out of The Buying Zone. Both indicate buyers stepping in strongly. NEVER Join in unless one showed up. Take Care.
NYSE:HIMS
by Faisalzor
Hims is OVERBOUGHT Market Context ✨ NYSE:HIMS | Current Price: $42.00 1-Month Move: +17.5% (from $35.75) 1-Year Move: +68.2% (from $25.00) Year High/Low: $43.50/$24.80 Technicals RSI: ~75.8 (overbought ) Moving Averages: Above 20-day, 50-day, and 200-day MAs (strong uptrend, but overextended ) MACD: Bearish divergence forming (momentum fading, potential reversal ) Trade Setup Direction: PUT Entry Price: $42.00 Take Profit 1 (TP1): $36.00 (~14.3% gain ) Take Profit 2 (TP2): $30.00 (~28.6% gain ) Expected Move: ~12–15% downward Best AI Signals on the market
NYSE:HIMSShort
by AlphaSignals_ai
5
Hims set to correctHims is pulling yet another amazing short squeeze. The stock has become my largest position by far since I got in back around 7$. These supply and demand zones have been drawn for a while. Note the amazing consolidation and push from the green demand box. 73$ would be double top mode. While I love the fundamentals I am not sure if the stock sis worth 70$ until we see next earnings which shouldn't be amazing because of their stated margin decreases, the market will panic like it always does. I would LOVE a retest of 35$, but 45$ is more likely.
NYSE:HIMSShort
by Apollo_21mil
HIMS – Pullback Opportunity After Massive RunHIMS has been one of the hottest stocks in the market recently, with a massive run fueled by strong earnings. But now we’re seeing the first meaningful pullback — and this could be a golden opportunity: 🔹 Earnings Gap Reversal (Bullish Signal) Despite an earnings gap down, buyers stepped in aggressively, pushing the stock higher. This is a classic earnings gap down reversal — a strong sign of demand. 🔹 First Pullback Opportunity Historically, the first pullback after a major run tends to get bought. I’m watching two key levels for a potential buy: The shaded zone between the 9 EMA and 20 EMA (dynamic support). The 0.38 - 0.50 Fibonacci retracement for added confirmation. 🔹 My Trading Plan: 1️⃣ Initial Entry: Starter position in the shaded EMA zone (9 EMA - 20 EMA). 2️⃣ Confirmation Add: If price bounces off the Fib zone (0.38 - 0.50) with strength. 3️⃣ Stop Loss: Below the 20 EMA for any initial position — keeping risk tight. 🔹 Why This Setup is Compelling: Strong run + earnings reversal shows real buyer interest. First pullback after a big run is typically a strong buying opportunity. The dual confluence of EMAs + Fibonacci enhances this setup. ⚠️ Risk Management: Tight stop below 20 EMA — always control risk.
NYSE:HIMSLong
by kunal00
1
HIMS: More Upside IMO but let's Review All ScenariosBullish Scenario If HIMS continues higher, we may see a shallow pullback first, possibly around 46.75, which lines up with one of my key levels and the uptrend line drawn from late April. A slightly deeper dip into the 10EMA would also be a healthy reset. From there, a move back through last week’s high and a continuation up along the uptrend line would confirm strength and keep this breakout intact. If momentum holds, I’m watching for a move toward 65, which sits just below the all-time high. This area could act as resistance, gearing up to establish a new ATH. If we get a new ATH, I’d could see the momentum gain to the upside from the excitement, then an immediate period of digestion, either sideways or a decline as buyers take profits. Neutral Scenario A sideways range around the current zone would be healthy digestion after the recent run. This could look like price holding between the retest levels (roughly 52–56), bouncing in a tight range as momentum resets. In this case, I’d watch for signs of strength on dips and whether volume dries up during consolidation. Bearish Scenario If HIMS breaks below 46.75, it could open the door for more downside, especially if sellers step in and follow through. That level is still above the EMAs, so the structure wouldn’t shift significantly unless price dips below the 10EMA and 20EMA. If that happens, I’d watch the 38 zone as the next key support, a previous base where price could stabilize or build a new setup. Below that, it could decline further around 33, where the first uptrend line and gap up was established (which also lines up with the 50SMA).
NYSE:HIMSLong
by emanuelaelias